Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.36 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.36 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PDE4A | P27815 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | BBOX1 | O75936 | 3/20 | 0.35 |
| ▸ | FABP3 | P05413 | 5/20 | 0.33 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.33 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.33 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.33 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2516912 | 0.95 | APP (0.44) | APPCA1HDAC3HDAC1HDAC2 | |
| SCHEMBL28668393 | 0.95 | CA1 (0.48) | APPCA1HDAC3HDAC1HDAC2 | |
| SCHEMBL17873523 | 0.86 | CA1 (0.44) | APPCA1HDAC3HDAC1HDAC2 | |
| SCHEMBL3563111 | 0.79 | FFAR3 (0.43) | APPCA1HDAC3HDAC1HDAC2 | |
| SCHEMBL8861434 | 0.78 | APP (0.38) | APPPTGS1PDE4ALMNASLC6A6 | |
| Succinic Acid SCHEMBL28245794 | 0.76 | CA1 (0.56) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL5022357 | 0.75 | CA1 (0.48) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Lithium Ion SCHEMBL2524489 | 0.75 | CA1 (0.42) | CA1HDAC3HDAC1HDAC2HDAC8 | |
| Potassium Ion SCHEMBL442400 | 0.75 | APP (0.39) | APPPTGS1PDE4ALMNASLC6A6 | |
| Adipic Acid SCHEMBL518167 | 0.74 | CA1 (0.58) | CA1HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9118062-B2 | Anode and method of manufacturing the same, and battery and method of manufacturing the same | SONY CORPORATION (JP) | 2015-08-25 | — | — | US | claimed |
| US-RE45310-E1 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2014-12-30 | — | — | US | claimed |
| US-20080311472-A1 | ANODE AND METHOD OF MANUFACTURING THE SAME, AND BATTERY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2008-12-18 | — | — | US | claimed |
| US-9118062-B2 | Anode and method of manufacturing the same, and battery and method of manufacturing the same | SONY CORPORATION (JP) | 2015-08-25 | — | — | US | disclosed |
| US-RE45310-E1 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2014-12-30 | — | — | US | disclosed |
| US-8613873-B2 | Anode, battery, and methods of manufacturing them | SONY CORPORATION (JP) | 2013-12-24 | — | — | US | disclosed |
| US-8394540-B2 | Anode and method of manufacturing same, secondary battery and method of manufacturing same, and sulfone compound | SONY CORPORATION (JP) | 2013-03-12 | — | — | US | disclosed |
| US-8377589-B2 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-02-19 | — | — | US | disclosed |
| US-8349489-B2 | Cathode active material, cathode therewith and nonaqueous electrolyte secondary battery | SONY CORPORATION (JP) | 2013-01-08 | — | — | US | disclosed |
| US-20120231335-A1 | CATHODE ACTIVE MATERIAL, CATHODE THEREWITH AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2012-09-13 | — | — | US | disclosed |
| US-20110250509-A1 | SECONDARY BATTERY AND ELECTRONIC DEVICE | SONY CORPORATION (JP) | 2011-10-13 | — | — | US | disclosed |
| US-20090263726-A1 | ANODE AND METHOD OF MANUFACTURING SAME, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | SONY CORPORATION (JP) | 2009-10-22 | — | — | US | disclosed |
| US-20090202905-A1 | CATHODE ACTIVE MATERIAL, CATHODE THEREWITH AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | SONY CORPORATION (JP) | 2009-08-13 | — | — | US | disclosed |
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | SONY CORPORATION (JP) | 2009-07-02 | — | — | US | disclosed |
| US-20090136855-A1 | ANODE, BATTERY, AND METHODS OF MANUFACTURING THEM | SONY CORPORATION (JP) | 2009-05-28 | — | — | US | disclosed |
| US-20080311472-A1 | ANODE AND METHOD OF MANUFACTURING THE SAME, AND BATTERY AND METHOD OF MANUFACTURING THE SAME | SONY CORPORATION (JP) | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090263726-A1 | ANODE AND METHOD OF MANUFACTURING SAME, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | STS, ASH2L, CACNA2D2 | APP 2314/4885CA1 14/4885HDAC3 1908/4885 |
| US-20090169985-A1 | ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND | CA12, CA1, STS | APP 3432/4885CA1 2/4885HDAC3 1945/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.